Safe Dose of Meloxicam for Adults
The safe and effective dose of meloxicam for adults is 7.5 mg once daily, with a maximum of 15 mg once daily if needed for adequate symptom control 1, 2.
Standard Dosing Recommendations
Based on guideline evidence and clinical trials, meloxicam dosing follows this framework:
- Starting dose: 7.5 mg once daily (oral)
- Maximum dose: 15 mg once daily
- Elderly patients: 7.5 mg daily maximum 1
- Administration: Single daily dose (long half-life allows once-daily dosing)
The evidence demonstrates that 7.5 mg and 15 mg daily doses are statistically superior to placebo for pain control and are maintained as effective throughout treatment 2. Lower doses of 3.75 mg did not consistently reach statistical significance for all efficacy endpoints 2.
Key Safety Considerations
Gastrointestinal Risk
The most critical safety concern with meloxicam relates to GI complications. The risk profile shows:
- 10-20% of patients experience dyspepsia or GI discomfort 1
- Age-dependent bleeding risk: ranges from 1 in 2,100 for adults under 45 years to 1 in 110 for adults over 75 years 1
- Meloxicam at 7.5-15 mg demonstrates GI tolerability comparable to placebo, which is superior to other NSAIDs like diclofenac 2
Cardiovascular Considerations
While COX-2 selective NSAIDs carry cardiovascular risks, meloxicam at standard doses (7.5-15 mg) showed similar rates of cardiovascular events compared to placebo in clinical trials 3.
Clinical Context and Formulations
Oral Formulations
Standard oral meloxicam tablets at 7.5-15 mg once daily remain the primary recommendation for chronic conditions like osteoarthritis 1, 2.
Intravenous Formulations
For acute postoperative pain, IV meloxicam at 30 mg once daily was generally well tolerated with rapid onset (as early as 15 minutes) and 24-hour duration 4. However, doses of 60 mg IV showed no additional efficacy benefit over 30 mg and higher doses (20 mg loading followed by maintenance) caused severe morbidity in some patients 5.
Common Pitfalls to Avoid
- Do not exceed 15 mg daily in standard adult patients - higher doses increase adverse events without proportional efficacy gains
- Do not use 15 mg in elderly patients - stick to 7.5 mg maximum 1
- Avoid in patients with history of NSAID-associated GI bleeding unless combined with proton pump inhibitor 1
- Do not combine with anticoagulants without gastroprotection - this increases bleeding risk 5-6 fold 1
Quality of Evidence
The dosing recommendations are supported by high-quality evidence including a large 12-week, double-blind, placebo-controlled trial of 774 patients 2 and comprehensive guideline recommendations from American Family Physician 1. The newer formulations (SoluMatrix, IV) show promise for lower-dose efficacy 6 but standard oral dosing at 7.5-15 mg remains the established safe range with the most robust long-term safety data.